<DOC>
	<DOCNO>NCT02425137</DOCNO>
	<brief_summary>Primary Objective : To evaluate disease control rate ( DCR ) S-1 combination gemcitabine patient advance biliary tract cancer Secondary Objectives : - To evaluate overall response rate ( ORR ) - To evaluate progression-free survival ( PFS ) - To evaluate overall survival ( OS ) - To assess safety profile</brief_summary>
	<brief_title>A Study S-1 Combination With Gemcitabine First-Line Treatment Patients With Advanced Biliary Tract Cancer</brief_title>
	<detailed_description />
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>1.histologically confirm biliary tract carcinoma ( include intrahepatic bile duct , extrahepatic bile duct , gallbladder , ampulla vater ) ; 2.metastatic unresectable disease ; 3.no history chemotherapy radiotherapy biliary tract cancer ; 4.presence least one measurable tumor lesion define lesion accurately measure least 1 dimension long diameter ( LD ) ≥20 mm use conventional technique ≥10 mm spiral CT MRI ; measurable lymph node must ≥15 mm short axis ; 5.adequate hematopoietic function define : 1. hemoglobin level ≥ 9 g/dL ; 2. absolute neutrophil count ( ANC ) ≥ 1,500/mm3 ; 3. platelet count ≥ 100,000/mm3 ; 6.adequate hepatic function define : 1. total bilirubin ≤ 1.5 time upper limit normal ( ULN ) &lt; 2 mg/dL , total bilirubin &lt; 3 mg/dL biliary drainage perform ; 2 . Alanine aminotransferase ( ALT ) ≤ 3 x ULN ALT ≤ 5 x ULN presence liver metastasis ; 7.adequate renal function : creatinine clearance rate ( CCr ) ≥ 60 mL/min ( ( base upon 24hour urine collection calculate CockroftGault formula ) ; 8.age 20 year ; 9.ECOG performance status 01 ; 10.life expectancy least 12 week ; 11.ability take oral medication ; 12.ability understand willingness sign write informed consent document . 1.other malignancy within past 5 year except adequately treat basal squamous cell skin cancer cervical cancer situ ; 2.history know presence brain metastasis ; 3.presence grade 2 ascites pleural effusion ; 4.presence grade 2 diarrhea ; 5.presence mental disease psychotic manifestation ; 6.active uncontrolled infection ; 7.significant medical condition contraindicate study medication render patient high risk treatment complication base investigator 's discretion ; 8.pregnant woman nurse mother , positive pregnancy test woman childbearing potential . Patients childbearing potential shall effective contraception patient partner study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>